Advanced searches left 3/3
Search only database of 8 mil and more summaries

Janssen Pharmaceuticals Inc

Summarized by PlexPage
Last Updated: 02 July 2021

* If you want to update the article please login/register

General | Latest Info

Johnson & Johnson is organized into three business segments: Pharmaceutical, Medical Devices and Consumer. The Pharmaceuticals segment operates in six primary therapeutic areas: immunology, oncology, neuroscience, cardiovascular and metabolic diseases, infectious diseases, and pulmonary hypertension. The segment's operating companies include Janssen Biotech and Janssen Pharmaceuticals. Its top selling drugs are Remicade and Stelara for arthritis and other inflammatory conditions; each drug brings in more than 5 billion in annual sales. Other key drugs include schizophrenia medication Invega Sustenna, rheumatoid arthritis drug Simponi, AIDS therapy Prezista, cardiovascular drug Xarelto, hypertension drug Opsumit, and cancer treatments Zytiga, Imbruvica, Darzalex, and Velcade. The Medical Devices segment focuses on surgery, orthopedics, Vision, and interventional Products including orthopaedic Products; general surgery, biosurgical, endomechanical and energy Products; electrophysiology Products to treat cardiovascular disease; and Vision Products such as disposable contact lenses and ophthalmic Products related to cataract and laser refractive surgery. The consumer segment includes beauty care brands Aveeno, Clean & Clear, and Neutrogena and a range of OTC Pharmaceuticals including Tylenol, Sudafed, and Benadryl. Other offerings include baby care, oral care, women's health, and wound care products. Headquarter in New Brunswick, US, J & J has approximately 260 operating companies in 60 countries selling products around the world. It has research facilities in more than a dozen countries and operates in about 100 manufacturing facilities in North America, Asia, Europe, and the Middle East. While the US and Europe represent the company's largest markets. The Asia-Pacific region and Africa together account for nearly 20% of revenue, while the non-US Western Hemisphere accounts for nearly 5%. J & J distributes its Pharmaceutical and Medical device products to retailers, wholesalers, and health care providers including hospitals. Products are marketed to consumers and health professionals. The company's Consumer Products are sold to the general public and sold online and to retail outlets and distributors throughout the world. J & J's three largest customers are wholesalers that distribute products across all three segments, each representing between 10% and 15% of sales. Advertising expenses worldwide, which comprise television, radio, print media and Internet advertising, were 2. 2 billion in 2019 2. 6 billion in 2018 and 2. 5 billion in 2017, respectively. In 2019, worldwide sales will increase 1% to 82. 1 billion as compared to an increase of 7% in 2018. Sales by US companies were 42. 1 billion in 2019 and 41. 9 billion in 2018. This represents an increase of 1% in 2019 and 5% in 2018. The company's net income in 2019 fell from 178 million to 15. 1 billion compared to 15. 3 billion in 2018. Fall was due to an increase in their operating expenses. Cash held by company at the end of 2019 fell by 802 million to 17. 3 billion compared to 18. 1 billion in 2018. Cash provided by operations was 23. 4 billion while cash used for investing and financing activities was 6. 2 billion and 18.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Donna Lewis

Docket alerts are an advanced feature of CourtListener. Monthly donors can create unlimited docket alerts. If you are not a monthly donor, we allow five alerts and give a bonus of 10 alerts to anybody with RECAP Extension instal. You currently have alerts. To create additional alerts, please install RECAP Extension or become a monthly donor. We can sometimes provide need-base exceptions to these rules. If you might need exception, please let US know. Complaint with Jury Demand against Actavis LLC, Actavis Pharma, INC., Cephalon, INC., Endo Health Solutions INC., Endo Pharmaceuticals, INC., Janssen Pharmaceuticals, INC., Janssen Pharmaceutica INC., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, INC., Purdue Pharma LP, Purdue Pharma, INC, TEVA Pharmaceuticals USA, INC., Purdue Frederick Company, INC., Watson Laboratories, INC., Watson Pharmaceuticals, INC., File by Michael Ray Lewis. Text ONLY ORDER GRANTING in part and denying in part 7 Separate Defendants Unopposed MOTION For Extension of Time to File Answer or Responsive Pleadings. Separate Defendants Responsive pleading must be File on or before SEPTEMBER 29 2017. Sign by the Honorable Timothy L. Brooks on August 16 2017. This TEXT-ONLY docket entry is an official and binding ORDER of court and is intentionally unaccompanied by separate document. Memorandum BRIEF in Support of 29 Joint MOTION to Dismiss by Actavis LLC, Actavis Pharma, INC., Cephalon, INC., Endo Health Solutions INC., Endo Pharmaceuticals, INC., Janssen Pharmaceuticals, INC., Janssen Pharmaceutica INC., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, INC., Purdue Pharma LP, Purdue Pharma, INC, TEVA Pharmaceuticals USA, INC., Purdue Frederick Company, INC., Watson Laboratories, INC., Watson Pharmaceuticals, INC. Text ONLY ORDER GRANTING 39 MOTION to Appear PRO Hac Vice. Donna M. Welch is directed to immediately register as CM / ECF user if she has not already done so and enter her appearance in this matter; and GRANTING 40 MOTION to Appear PRO Hac Vice. Jennifer G. Levy is directed to immediately register as CM / ECF user if she has not already done so and enter her appearance in this matter. Sign by the Honorable Timothy L. Brooks on October 2 2017. Text ONLY ORDER GRANTING 41 MOTION to Appear PRO Hac Vice. Martin L. Roth is directed to immediately register as CM / ECF user if he has not already done so and enter his appearance in this matter; and GRANTING 42 MOTION to Appear PRO Hac Vice. Timothy w. Knapp is directed to immediately register as CM / ECF user if he has not already done so and enter his appearance in this matter. Sign by the Honorable Timothy L. Brooks on October 2 2017. Text ONLY ORDER GRANTING 46 MOTION to Appear PRO Hac Vice. Charles C. Lifland is directed to immediately register as CM / ECF user if he has not already done so and enter his appearance in this matter; and GRANTING 47 MOTION to Appear PRO Hac Vice. Jennifer D. Cardelus is directed to immediately register as CM / ECF user if she has not already done so and enter her appearance in this matter; and GRANTING 48 MOTION to Appear PRO Hac Vice.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.